https://www.indianpharmapost.com/sumitomo-pharmas-enzomenib-gets-orphan-drug-designation-by-us-fda-212072026-08-04T00:00:00+05:30always0.9https://www.indianpharmapost.com/india-surpasses-20000-organ-transplants-in-2025-govt-launches-digital-platform-212192026-08-04T00:00:00+05:30always0.9https://www.indianpharmapost.com/kims-hospitals-reports-361-jump-in-first-quarter-revenue-to-rs-11959-crore-212202026-08-04T00:00:00+05:30always0.9https://www.indianpharmapost.com/biocon-launches-interchangeable-biosimilar-yesafili-for-retinal-diseases-in-us-market-212212026-08-04T00:00:00+05:30always0.9https://www.indianpharmapost.com/gpt-healthcare-posts-18-revenue-growth-in-q1-fy27-pat-jumps-66-212222026-08-04T00:00:00+05:30always0.9https://www.indianpharmapost.com/artemis-medicare-reports-rs-28732-crore-revenue-at-13-growth-in-q1-fy27-212232026-08-04T00:00:00+05:30always0.9